Benzinga

Benzinga

Benzinga

lundi, août 31

Cardinal Health Inc

CAHNYSE
Trade with Public
Trade with Public
$234.55
-0.58-0.25%
À la clôture: Aug 28, 5:00 PM EST
$235.36
0.810.35%
Après les heures: Aug 28, 4:01 PM EST
AperçuActualitésPrévisions de résultatsÉvénementsObjectifs de coursDonnées financièresSentimentActionnariatDividendesComparerOptionsRapport sur les stocks

Cardinal Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Cardinal Health (CAH).

Price Target Range — 12 Quarters

Analyst Consensus — 17 Analysts

15Buy
2Hold
Consensus RatingBuy# Analysts17Avg. Consensus PT$224Upside to Avg. PT-4.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 19, 2026RBC CapitalRyan HalstedInitiateOutperform$276
Aug 13, 2026TD CowenCharles RhyeePT RaiseBuy$275→$280
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276

RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.
Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280

TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.
Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260

JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.
Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275

Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.
Benzinga Newsdesk

PRO
Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.
Benzinga Newsdesk

PRO
Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265

Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.
Benzinga Newsdesk

Données et API: API Benzinga · API d'actualités boursières · API de notations d'analystes · API de logo d'entreprise

Données de marché fournies par API Benzinga

Benzinga

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL

© 2026 Benzinga | All Rights Reserved